Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cortese

Showing results (141-150 of 185) with videos related to

Pageof 19
Sort By:
Biochemistry|June 24, 1998
Product inhibition of the hepatitis C virus NS3 proteaseC Steinkühler, G Biasiol, M Brunetti, et al.
European Journal of Immunology|November 22, 1997
Induction of anti-carbohydrate antibodies by phage library-selected peptide mimicsA Phalipon, A Folgori, J Arondel, et al.
Biochemical and Biophysical Research Communications|July 16, 1985
Cloning and sequencing of a full length cDNA corresponding to human cellular retinol-binding proteinV Colantuoni, R Cortese, M Nilsson, et al.
Atherosclerosis|December 1, 1985
Molecular cloning of human LDL apolipoprotein B cDNA. Evidence for more than one gene per haploid genomeC C Shoulders, N B Myant, A Sidoli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1996
Nonrheumatoid IgM in human hepatitis C virus-associated type II cryoglobulinemia recognize mimotopes of the CD4-like LAG-3 proteinM Mecchia, M Casato, R Tafi, et al.
Current Opinion in Biotechnology|February 1, 1995
Identification of biologically active peptides using random libraries displayed on phageR Cortese, P Monaci, A Nicosia, et al.
Journal of Autoimmunity|June 1, 1996
Selection of phage-displayed peptides mimicking type 1 diabetes-specific epitopesC Mennuni, C Santini, F Dotta, et al.
Hepatology (Baltimore, Md.)|March 7, 2001
Mimotopes of the hepatitis C virus hypervariable region 1, but not the natural sequences, induce cross-reactive antibody response by genetic immunizationS Zucchelli, R Roccasecca, A Meola, et al.
Biochemistry|June 24, 1998
Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage productsP Ingallinella, S Altamura, E Bianchi, et al.
The EMBO Journal|June 3, 1996
Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivityC Toniatti, A Cabibbo, E Sporena, et al.
Pageof 19

Showing results (141-150 of 185) with videos related to

Sort By:
Pageof 19
Biochemistry|June 24, 1998
Product inhibition of the hepatitis C virus NS3 proteaseC Steinkühler, G Biasiol, M Brunetti, et al.
European Journal of Immunology|November 22, 1997
Induction of anti-carbohydrate antibodies by phage library-selected peptide mimicsA Phalipon, A Folgori, J Arondel, et al.
Biochemical and Biophysical Research Communications|July 16, 1985
Cloning and sequencing of a full length cDNA corresponding to human cellular retinol-binding proteinV Colantuoni, R Cortese, M Nilsson, et al.
Atherosclerosis|December 1, 1985
Molecular cloning of human LDL apolipoprotein B cDNA. Evidence for more than one gene per haploid genomeC C Shoulders, N B Myant, A Sidoli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1996
Nonrheumatoid IgM in human hepatitis C virus-associated type II cryoglobulinemia recognize mimotopes of the CD4-like LAG-3 proteinM Mecchia, M Casato, R Tafi, et al.
Current Opinion in Biotechnology|February 1, 1995
Identification of biologically active peptides using random libraries displayed on phageR Cortese, P Monaci, A Nicosia, et al.
Journal of Autoimmunity|June 1, 1996
Selection of phage-displayed peptides mimicking type 1 diabetes-specific epitopesC Mennuni, C Santini, F Dotta, et al.
Hepatology (Baltimore, Md.)|March 7, 2001
Mimotopes of the hepatitis C virus hypervariable region 1, but not the natural sequences, induce cross-reactive antibody response by genetic immunizationS Zucchelli, R Roccasecca, A Meola, et al.
Biochemistry|June 24, 1998
Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage productsP Ingallinella, S Altamura, E Bianchi, et al.
The EMBO Journal|June 3, 1996
Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivityC Toniatti, A Cabibbo, E Sporena, et al.
Pageof 19